Stock Track | HJ SCIENCE-B Plummets 5.01% Intraday as Clinical-Stage Biotech Debuts with No Revenue or Approved Products

Stock Track09:34

HJ SCIENCE-B (06132) saw its stock price plummet 5.01% during intraday trading on Tuesday, shortly after its debut on the Hong Kong exchange.

The company is a clinical-stage biotechnology firm with three core products—HJ787, HJ178, and HJ891—all classified as Category 1 innovative drugs but still awaiting regulatory approval. According to its prospectus, HJ SCIENCE-B has not yet received approval for the commercial sale of any products and has generated no revenue from product sales to date.

Investor sentiment appeared cautious as the market assessed the company's early-stage development status and lack of commercial track record, despite its integrated drug development platform covering everything from drug design to clinical studies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169390619?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 09:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169390619","market":"nz","top_or_hot":-1,"title":"Stock Track | HJ SCIENCE-B Plummets 5.01% Intraday as Clinical-Stage Biotech Debuts with No Revenue or Approved Products","media":"Stock Track","content":"<p>HJ SCIENCE-B (06132) saw its stock price plummet 5.01% during intraday trading on Tuesday, shortly after its debut on the Hong Kong exchange.</p><p>The company is a clinical-stage biotechnology firm with three core products—HJ787, HJ178, and HJ891—all classified as Category 1 innovative drugs but still awaiting regulatory approval. According to its prospectus, HJ SCIENCE-B has not yet received approval for the commercial sale of any products and has generated no revenue from product sales to date.</p><p>Investor sentiment appeared cautious as the market assessed the company's early-stage development status and lack of commercial track record, despite its integrated drug development platform covering everything from drug design to clinical studies.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | HJ SCIENCE-B Plummets 5.01% Intraday as Clinical-Stage Biotech Debuts with No Revenue or Approved Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | HJ SCIENCE-B Plummets 5.01% Intraday as Clinical-Stage Biotech Debuts with No Revenue or Approved Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-06-23 09:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HJ SCIENCE-B (06132) saw its stock price plummet 5.01% during intraday trading on Tuesday, shortly after its debut on the Hong Kong exchange.</p><p>The company is a clinical-stage biotechnology firm with three core products—HJ787, HJ178, and HJ891—all classified as Category 1 innovative drugs but still awaiting regulatory approval. According to its prospectus, HJ SCIENCE-B has not yet received approval for the commercial sale of any products and has generated no revenue from product sales to date.</p><p>Investor sentiment appeared cautious as the market assessed the company's early-stage development status and lack of commercial track record, despite its integrated drug development platform covering everything from drug design to clinical studies.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06132","symbol_name":"华健未来-B","start_time":0,"source_url":"","article_id":"1169390619","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169390619","pubTimestamp":1782178468,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"HJ SCIENCE-B (06132) saw its stock price plummet 5.01% during intraday trading on Tuesday, shortly after its debut on the Hong Kong exchange.The company is a clinical-stage biotechnology firm with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06132":"华健未来-B"},"translate_title":"个股追踪|HJ SCIENCE-B盘中暴跌5.01%，临床阶段生物技术首次亮相无营收或获批产品","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06132":1},"content_text":"HJ SCIENCE-B (06132) saw its stock price plummet 5.01% during intraday trading on Tuesday, shortly after its debut on the Hong Kong exchange.The company is a clinical-stage biotechnology firm with three core products—HJ787, HJ178, and HJ891—all classified as Category 1 innovative drugs but still awaiting regulatory approval. According to its prospectus, HJ SCIENCE-B has not yet received approval for the commercial sale of any products and has generated no revenue from product sales to date.Investor sentiment appeared cautious as the market assessed the company's early-stage development status and lack of commercial track record, despite its integrated drug development platform covering everything from drug design to clinical studies.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169390619","isCrawlerRequest":true}